Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis
Pauline Vercruysse, Jérôme Sinniger, Hajer El Oussini, et al.
Brain (2016) Vol. 139, Iss. 4, pp. 1106-1122
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Energy metabolism in ALS: an underappreciated opportunity?
Tijs Vandoorne, Katrien De Bock, Ludo Van Den Bosch
Acta Neuropathologica (2018) Vol. 135, Iss. 4, pp. 489-509
Open Access | Times Cited: 220
Effect of High‐Caloric Nutrition on Survival in Amyotrophic Lateral Sclerosis
Albert C. Ludolph, Johannes Dorst, Jens Dreyhaupt, et al.
Annals of Neurology (2019) Vol. 87, Iss. 2, pp. 206-216
Closed Access | Times Cited: 146
Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism
Pauline Vercruysse, Didier Vieau, David Blum, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 11
Open Access | Times Cited: 147
Hypothalamic atrophy is related to body mass index and age at onset in amyotrophic lateral sclerosis
Martin Gorges, Pauline Vercruysse, Hans‐Peter Müller, et al.
Journal of Neurology Neurosurgery & Psychiatry (2017) Vol. 88, Iss. 12, pp. 1033-1041
Closed Access | Times Cited: 138
Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: results from the ALS registry Swabia
Raphael S. Peter, Angela Rosenbohm, Luc Dupuis, et al.
European Journal of Epidemiology (2017) Vol. 32, Iss. 10, pp. 901-908
Closed Access | Times Cited: 97
Disease-modifying and symptomatic treatment of amyotrophic lateral sclerosis
Johannes Dorst, Albert C. Ludolph, Annemarie Huebers
Therapeutic Advances in Neurological Disorders (2017) Vol. 11
Open Access | Times Cited: 95
Hypermetabolism is a deleterious prognostic factor in patients with amyotrophic lateral sclerosis
Pierre Jésus, P. Fayemendy, Marie Nicol, et al.
European Journal of Neurology (2017) Vol. 25, Iss. 1, pp. 97-104
Closed Access | Times Cited: 91
Climate change and neurodegenerative diseases
Paolo Bongioanni, R. Del Carratore, Silvia Corbianco, et al.
Environmental Research (2021) Vol. 201, pp. 111511-111511
Closed Access | Times Cited: 72
Nutritional and metabolic factors in amyotrophic lateral sclerosis
Albert C. Ludolph, Luc Dupuis, Edward J. Kasarskis, et al.
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 511-524
Closed Access | Times Cited: 29
Proteostasis failure exacerbates neuronal circuit dysfunction and sleep impairments in Alzheimer’s disease
Christopher D. Morrone, Radha Raghuraman, S. Abid Hussaini, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 27
Early-onset sleep alterations found in patients with amyotrophic lateral sclerosis are ameliorated by orexin antagonist in mouse models
Simon J. Guillot, Christina Lang, Marie Simonot, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 783
Closed Access | Times Cited: 1
Physiological changes in neurodegeneration — mechanistic insights and clinical utility
Rebekah M. Ahmed, Yazi D. Ke, Steve Vucic, et al.
Nature Reviews Neurology (2018) Vol. 14, Iss. 5, pp. 259-271
Closed Access | Times Cited: 77
What is “Hyper” in the ALS Hypermetabolism?
Alberto Ferri, Roberto Coccurello
Mediators of Inflammation (2017) Vol. 2017, pp. 1-11
Open Access | Times Cited: 71
Sphingolipid Metabolism Is Dysregulated at Transcriptomic and Metabolic Levels in the Spinal Cord of an Animal Model of Amyotrophic Lateral Sclerosis
Alexandre Henriques, Vincent Croixmarie, Alexandra Bouscary, et al.
Frontiers in Molecular Neuroscience (2018) Vol. 10
Open Access | Times Cited: 59
Loss of appetite is associated with a loss of weight and fat mass in patients with amyotrophic lateral sclerosis
Shyuan T. Ngo, Ruben P.A. van Eijk, Veronique Chachay, et al.
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration (2019) Vol. 20, Iss. 7-8, pp. 497-505
Open Access | Times Cited: 56
Evidence of Metabolic Dysfunction in Amyotrophic Lateral Sclerosis (ALS) Patients and Animal Models
Katarina Maksimovic, Mohieldin Youssef, Justin You, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 863-863
Open Access | Times Cited: 21
Association of blood lipids with onset and prognosis of amyotrophic lateral sclerosis: results from the ALS Swabia registry
Sebastian Michels, Deborah Kurz, Angela Rosenbohm, et al.
Journal of Neurology (2023) Vol. 270, Iss. 6, pp. 3082-3090
Open Access | Times Cited: 18
Altered Metabolic Homeostasis in Amyotrophic Lateral Sclerosis: Mechanisms of Energy Imbalance and Contribution to Disease Progression
Zara A. Ioannides, Shyuan T. Ngo, Robert D. Henderson, et al.
Neurodegenerative Diseases (2016) Vol. 16, Iss. 5-6, pp. 382-397
Closed Access | Times Cited: 55
Cognition and eating behavior in amyotrophic lateral sclerosis: effect on survival
Rebekah M. Ahmed, Jashelle Caga, Emma Devenney, et al.
Journal of Neurology (2016) Vol. 263, Iss. 8, pp. 1593-1603
Closed Access | Times Cited: 54
Lipid Metabolism and Survival Across the Frontotemporal Dementia-Amyotrophic Lateral Sclerosis Spectrum: Relationships to Eating Behavior and Cognition
Rebekah M. Ahmed, Elizabeth Highton‐Williamson, Jashelle Caga, et al.
Journal of Alzheimer s Disease (2017) Vol. 61, Iss. 2, pp. 773-783
Closed Access | Times Cited: 51
Lipid Biomarkers for Amyotrophic Lateral Sclerosis
José‐Luis González de Aguilar
Frontiers in Neurology (2019) Vol. 10
Open Access | Times Cited: 50
Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany
Gabriele Nagel, Raphael S. Peter, Angela Rosenbohm, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 49
Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis
Matei Bolborea, Pauline Vercruysse, Tselmen Daria, et al.
Acta Neuropathologica (2023) Vol. 145, Iss. 6, pp. 773-791
Open Access | Times Cited: 13
Non-motor symptoms in patients with amyotrophic lateral sclerosis: current state and future directions
Bogdan Bjelica, M. Bartels, Jasper Hesebeck‐Brinckmann, et al.
Journal of Neurology (2024) Vol. 271, Iss. 7, pp. 3953-3977
Open Access | Times Cited: 5
Association Between Hypothalamic Volume and Metabolism, Cognition, and Behavior in Patients With Amyotrophic Lateral Sclerosis
Annebelle Michielsen, Kevin van Veenhuijzen, Mark R. Janse van Mantgem, et al.
Neurology (2024) Vol. 103, Iss. 2
Open Access | Times Cited: 5
Page 1 - Next Page

Scroll to top